These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24621512)

  • 1. Nicotine activates YAP1 through nAChRs mediated signaling in esophageal squamous cell cancer (ESCC).
    Zhao Y; Zhou W; Xue L; Zhang W; Zhan Q
    PLoS One; 2014; 9(3):e90836. PubMed ID: 24621512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma.
    Wang C; Cheng L; Song S; Wu S; Sun G
    J Cell Physiol; 2020 Nov; 235(11):8224-8235. PubMed ID: 31957872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.
    Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP
    Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1.
    Silvis MR; Kreger BT; Lien WH; Klezovitch O; Rudakova GM; Camargo FD; Lantz DM; Seykora JT; Vasioukhin V
    Sci Signal; 2011 May; 4(174):ra33. PubMed ID: 21610251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma.
    Chai Y; Li Q; Zhao H; Zhang Z; Yu X; Pang L; Liu Z; Zhao J; Wang L; Li F
    Cancer Med; 2019 Nov; 8(16):7055-7064. PubMed ID: 31560173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Ben Q; An W; Sun Y; Qian A; Liu J; Zou D; Yuan Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):181. PubMed ID: 32894161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway.
    Li P; Silvis MR; Honaker Y; Lien WH; Arron ST; Vasioukhin V
    Genes Dev; 2016 Apr; 30(7):798-811. PubMed ID: 27013234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1).
    He S; Zhang H; Xiao Z; Bhushan S; Gao K; Wang W
    Bioengineered; 2021 Dec; 12(1):601-614. PubMed ID: 33517828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation.
    Kawazoe T; Saeki H; Oki E; Oda Y; Maehara Y; Mori M; Taniguchi K
    Mol Cancer Res; 2020 Dec; 18(12):1876-1888. PubMed ID: 33004621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal Localization and Tumor Suppressor Function of Epithelial Tissue-Specific Transcription Factor ESE3 in Esophageal Squamous Cell Carcinoma.
    Wang L; Xing J; Cheng R; Shao Y; Li P; Zhu S; Zhang S
    PLoS One; 2015; 10(5):e0126319. PubMed ID: 25950810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.
    Song S; Honjo S; Jin J; Chang SS; Scott AW; Chen Q; Kalhor N; Correa AM; Hofstetter WL; Albarracin CT; Wu TT; Johnson RL; Hung MC; Ajani JA
    Clin Cancer Res; 2015 Jun; 21(11):2580-90. PubMed ID: 25739674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.
    Baia GS; Caballero OL; Orr BA; Lal A; Ho JS; Cowdrey C; Tihan T; Mawrin C; Riggins GJ
    Mol Cancer Res; 2012 Jul; 10(7):904-13. PubMed ID: 22618028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma.
    Song S; Xie M; Scott AW; Jin J; Ma L; Dong X; Skinner HD; Johnson RL; Ding S; Ajani JA
    Mol Cancer Ther; 2018 Feb; 17(2):443-454. PubMed ID: 29167315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the expression of the oncogene YAP1, a Wnt/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients.
    Abduch RH; Carolina Bueno A; Leal LF; Cavalcanti MM; Gomes DC; Brandalise SR; Masterallo MJ; Yunes JA; Martinelli CE; Tone LG; Tucci S; Molina CA; Ramalho FS; Moreira AC; Cardinalli IA; Scrideli CA; Ramalho LN; de Castro M; Antonini SR
    Oncotarget; 2016 Dec; 7(51):84634-84644. PubMed ID: 27705928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma.
    Alzahrani F; Clattenburg L; Muruganandan S; Bullock M; MacIsaac K; Wigerius M; Williams BA; Graham ME; Rigby MH; Trites JR; Taylor SM; Sinal CJ; Fawcett JP; Hart RD
    J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):15. PubMed ID: 28222762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
    Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
    Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP1 negatively regulates chondrocyte differentiation partly by activating the β-catenin signaling pathway.
    Yang B; Sun H; Song F; Yu M; Wu Y; Wang J
    Int J Biochem Cell Biol; 2017 Jun; 87():104-113. PubMed ID: 28438716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis.
    Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF
    Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.
    Kim J; McMillan E; Kim HS; Venkateswaran N; Makkar G; Rodriguez-Canales J; Villalobos P; Neggers JE; Mendiratta S; Wei S; Landesman Y; Senapedis W; Baloglu E; Chow CB; Frink RE; Gao B; Roth M; Minna JD; Daelemans D; Wistuba II; Posner BA; Scaglioni PP; White MA
    Nature; 2016 Oct; 538(7623):114-117. PubMed ID: 27680702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.